Delivery Order SPE2DB22D3009-SPE2DB25FBF10
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Sevoflurane Inhalation Liquid in 250mL units, with a ceiling value of $6,407.10 and a firm fixed price contract type. The delivery order is scheduled for completion by July 31, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities, with a ceiling value of $3,009.44. This was a firm fixed price contract awarded on September 9, 2025, with an ultimate completion date of September 10, 2025. The award represents a non-set-aside, competitively awarded procurement with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,713.60 to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities. This contract, which was competitively awarded without set-aside designation, carries a firm fixed price structure with an ultimate completion date of August 29, 2025. The award was made to support federal medical procurement needs, with the place of performance located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,775.04 to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities. This contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The delivery order was awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Sevoflurane is...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Sevoflurane Inhalation Liquid in 250mL quantities, with a ceiling value of $4,649.76. This firm fixed price delivery order, issued on August 28, 2025, represents a non-competitive set-aside award and is scheduled for ultimate completion by August 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml units, valued at $3,299.52 with a firm fixed price structure. The award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen will perform this delivery from its Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ml units with a ceiling value of $1,656.66. This firm fixed-price delivery order, which must be completed by July 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open...
- The Defense Logistics Agency awarded a delivery order valued at $1,885.44 to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250mL quantities. This contract was competitively awarded without set-aside provisions and operates under a firm fixed-price arrangement, with an ultimate completion date of August 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete...
- The Defense Logistics Agency awarded a $2,373.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for 250 milliliters of Sevoflurane inhalation liquid, with an ultimate completion date of September 3, 2025. This is a non-set-aside competitive award issued to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,979.33 to AmerisourceBergen Drug Corp on April 25, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ml quantities. This is a firm fixed-price contract with an ultimate completion date of April 28, 2025, and carries no set-aside designation, indicating it was competitively awarded. The award was placed to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Sevoflurane is a volatile...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBF10Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities, with a contract ceiling value of $1,414.08. This award, issued on September 15, 2025, represents a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded competitively without a set-aside designation, reflecting the company's established capability to meet federal pharmaceutical procurement requirements. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, and medical supplies to support military healthcare programs worldwide. Sevoflurane, an inhalation anesthetic commonly used in surgical and medical procedures, falls within the broad therapeutic portfolio covered under this prime vendor agreement, which supports the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/15/25 |